Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study

BACKGROUND: Mesothelioma is an aggressive thoracic tumour with a poor prognosis. The only treatment that extends survival is chemotherapy. However, in the UK, up to 50% of patients who are suitable for chemotherapy choose not to receive it, opting for active symptom control instead. The aim of this...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Palliat Care
Main Authors: Bibby, Anna C., De Fonseka, Duneesha, Morley, Anna J., Keenan, Emma, Addeo, Alfredo, Smith, Sarah, Edey, Anthony J., Maskell, Nick A.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5723074/
https://ncbi.nlm.nih.gov/pubmed/29221485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12904-017-0255-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados